Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Head and Neck Neoplasms 1869Squamous Cell Carcinoma of Head and Neck 1109Nasopharyngeal Carcinoma 535Thyroid Neoplasms 518Mouth Neoplasms 347Oropharyngeal Neoplasms 292Laryngeal Neoplasms 197Neoplasms 187Carcinoma, Squamous Cell 187Breast Neoplasms 183Lung Neoplasms 181Nasopharyngeal Neoplasms 160Thyroid Nodule 154Salivary Gland Neoplasms 135Thyroid Cancer, Papillary 122Neoplasm Metastasis 113Carcinoma, Non-Small-Cell Lung 112Hypopharyngeal Neoplasms 111Melanoma 105Prostatic Neoplasms 99Esophageal Neoplasms 95Colorectal Neoplasms 90Thyroid Diseases 86Uterine Cervical Neoplasms 82Recurrence 81Pancreatic Neoplasms 79Ovarian Neoplasms 70Sarcoma 68Stomach Neoplasms 65Xerostomia 62

Interventions

prednylidene 1exifone 1deltacortene 1Prednisone 1Methylprednisolone 1Medrol Veriderm 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cranial Nerve Diseases × Head & Neck × Clear all
NCT04151082 2026-01-13

High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
35 enrolled
Head & Neck

Cranial Nerve Diseases, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡